PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19447677-7	2009	Further, T-cell responses to RD1 peptides were lower in the 23 active-TB treated patients than in the untreated ones (p<0.01).	Terbium	70-72	phosphodiesterase 6B	Homo sapiens	29-32	
26885516-0	2016	Identification of Novel RD1 Antigens and Their Combinations for Diagnosis of Sputum Smear-/Culture+ TB Patients.	Terbium	100-102	phosphodiesterase 6B	Homo sapiens	24-27	
19250549-9	2009	CONCLUSION: IFN-gamma-producing RD1-specific T cells, as measured in the T-SPOT.TB assay, may be directly related to bacterial load in patients undergoing treatment for pulmonary TB.	Terbium	80-82	phosphodiesterase 6B	Homo sapiens	32-35	
18686610-2	2008	METHODS: We used ex vivo gamma-interferon enzyme-linked immunospot assays to test T cell responses to three novel gene products encoded by RD1 (Rv3873, Rv3878, and Rv3879c) in 49 patients (TB group) who were bacteriologically confirmed by positive cultures for MTB and 38 healthy BCG-vaccinated donors (control group).	Terbium	189-191	phosphodiesterase 6B	Homo sapiens	139-142	
16700703-7	2006	The RD1 selected peptides assay had the highest diagnostic odds ratio for A-TB.	Terbium	76-78	phosphodiesterase 6B	Homo sapiens	4-7	
16700703-8	2006	Thus, the results suggest that an assay based on RD1 selected peptides has a higher diagnostic accuracy for A-TB in a clinical setting compared with commercially available assays based on RD1 overlapping peptides.	Terbium	110-112	phosphodiesterase 6B	Homo sapiens	49-52